Gujarat Themis Biosyn Stock Screener | Share Price & Fundamental Analysis
GUJTHEM
Pharmaceuticals
Screen Gujarat Themis Biosyn share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹425.85
▼
-9.35 (-2.15%)
Share Price BSE
₹423.15
▼
-12.40 (-2.85%)
Market Cap
₹4,734.00 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
18.23
EPS (TTM)
₹4.48
Dividend Yield
0.15%
Debt to Equity
0.07
52W High
₹469.90
52W Low
₹218.91
Operating Margin
45.00%
Profit Margin
30.38%
Revenue (TTM)
₹158.00
EBITDA
₹73.00
Net Income
₹48.00
Total Assets
₹301.00
Total Equity
₹248.00
Gujarat Themis Biosyn Share Price History - Stock Screener Chart
Screen GUJTHEM historical share price movements with interactive charts. Analyze price trends and patterns.
Gujarat Themis Biosyn Company Profile - Fundamental Screener
Screen Gujarat Themis Biosyn company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for GUJTHEM shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE942C01045
Gujarat Themis Biosyn Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen GUJTHEM balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 301 | 221 | 166 | 123 | 88 | 64 | 33 | 21 | 21 | 15 |
| Current Assets | 52 | 48 | 62 | 78 | 63 | 29 | 8 | 8 | 8 | 3 |
| Fixed Assets | 41 | 38 | 33 | 19 | 19 | 17 | 15 | 11 | 11 | 9 |
| Liabilities | ||||||||||
| Total Liabilities | 301 | 221 | 166 | 123 | 88 | 64 | 33 | 21 | 21 | 15 |
| Current Liabilities | 32 | 4 | 2 | 2 | 3 | 5 | 1 | 1 | 1 | 2 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 248 | 201 | 149 | 103 | 70 | 42 | 19 | 12 | 8 | 4 |
| Share Capital | 11 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves & Surplus | 238 | 194 | 142 | 96 | 63 | 35 | 11 | 5 | 1 | -3 |
Screen GUJTHEM income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 158 | 153 | 174 | 155 | 119 | 94 | 87 | 43 | 39 | 36 | 33 | 32 |
| Expenses | 86 | 81 | 91 | 75 | 57 | 50 | 53 | 34 | 33 | 30 | 27 | 25 |
| EBITDA | 73 | 71 | 83 | 80 | 62 | 44 | 34 | 10 | 6 | 6 | 6 | 6 |
| Operating Profit % | 45.00% | 46.00% | 46.00% | 50.00% | 51.00% | 45.00% | 37.00% | 18.00% | 16.00% | 17.00% | 19.00% | 20.00% |
| Depreciation | 8 | 5 | 4 | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 64 | 66 | 79 | 78 | 59 | 41 | 31 | 8 | 5 | 5 | 5 | 5 |
| Tax | 14 | 17 | 20 | 20 | 15 | 11 | 8 | 2 | 1 | 1 | 0 | 0 |
| Net Profit | 48 | 49 | 59 | 58 | 44 | 30 | 24 | 6 | 4 | 4 | 5 | 5 |
| EPS | 4.40 | 4.48 | 40.72 | 39.90 | 30.03 | 20.77 | 16.30 | 4.41 | 2.66 | 3.01 | 3.19 | 3.16 |
Gujarat Themis Biosyn Cash Flow Screener - Liquidity Fundamentals
Screen GUJTHEM cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 91 | 64 | 40 | 40 | 11 | 1 | 1 | 6 | 3 | 4 |
| Investing Activities | -112 | -55 | -20 | -30 | -2 | -3 | -6 | -1 | -3 | -1 |
| Financing Activities | 26 | -9 | -13 | -14 | -5 | 2 | 5 | -4 | 0 | -3 |
| Net Cash Flow | 5 | 0 | 6 | -4 | 3 | 0 | 0 | 1 | 0 | 0 |
Screen GUJTHEM shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2025-Feb | 2024-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 70.86% | 70.86% | 70.86% | 70.86% | 70.86% | 70.86% | 70.86% | 70.86% |
| FII Holding | 2.95% | 2.51% | 1.91% | 0.00% | 1.42% | 1.05% | 1.44% | 1.49% |
| DII Holding | 1.17% | 1.17% | 1.17% | 1.16% | 1.17% | 0.82% | 1.18% | 1.17% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 18.72% | 19.31% | 19.66% | 19.75% | 20.12% | 22.26% | 21.17% | 20.44% |
| Other Holding | 6.29% | 6.14% | 6.39% | 8.22% | 6.42% | 5.00% | 5.35% | 6.03% |
| Shareholder Count | 28,319 | 28,945 | 30,673 | 30,695 | 30,934 | 29,576 | 30,280 | 31,271 |
Gujarat Themis Biosyn Dividend Screener - Share Yield Analysis
Screen GUJTHEM dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.67 | 0.15% |
| 2024-March | ₹1.00 | 0.35% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Gujarat Themis Biosyn Index Membership - Market Screener Classification
Screen GUJTHEM by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Gujarat Themis Biosyn Market Events Screener - Corporate Actions
Screen GUJTHEM market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 0.67 /share | 14.14% | ||
| Annual General Meeting | NA | 5.18% | ||
| Dividend | ₹ 1.00 /share | 1.31% | ||
| 2025-11-10 | 2025-11-10 | Quarterly Result Announcement | NA | -2.76% |
| 2025-08-01 | 2025-08-01 | Quarterly Result Announcement | NA | 7.60% |
| 2025-05-20 | 2025-05-20 | Quarterly Result Announcement | NA | 6.23% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -12.92% |
| 2024-10-25 | 2024-10-25 | Quarterly Result Announcement | NA | -7.92% |
| 2024-08-09 | 2024-08-09 | Bonus | 1:2 | 3.18% |
| 2024-07-23 | 2024-07-23 | Annual General Meeting | NA | 15.98% |
| 2024-07-15 | 2024-07-16 | Dividend | ₹ 0.25 /share | 20.54% |
| 2024-02-22 | 2024-02-22 | Dividend | ₹ 0.75 /share | -2.29% |
| 2023-10-10 | 2023-05-13 | Split | 1:5 | 0.00% |
| 2022-12-01 | 2022-12-02 | Dividend | ₹ 4.40 /share | -9.39% |
| 2022-08-29 | 2022-08-31 | Dividend | ₹ 4.00 /share | 19.34% |
Gujarat Themis Biosyn Competitors Screener - Peer Comparison
Screen GUJTHEM competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 411,990 | 39.35 | 54,729 | 9.71% | 10,980 | 38.94 |
| Divis Laboratories | 168,148 | 68.31 | 9,712 | 18.67% | 2,191 | 47.61 |
| Torrent Pharmaceuticals | 130,014 | 60.76 | 11,539 | 6.99% | 1,911 | 63.27 |
| Cipla | 121,190 | 22.46 | 28,410 | 7.12% | 5,291 | 50.85 |
| Dr Reddys Laboratories | 104,295 | 18.49 | 33,741 | 16.73% | 5,725 | 53.02 |
| Lupin | 95,987 | 22.19 | 22,910 | 13.74% | 3,306 | 57.47 |
| Zydus Life Science | 91,894 | 18.30 | 23,511 | 18.55% | 4,615 | 43.59 |
| Mankind Pharma | 89,451 | 51.11 | 12,744 | 20.90% | 2,007 | 49.10 |
| Aurobindo Pharma | 68,825 | 20.05 | 32,346 | 9.43% | 3,484 | 45.26 |
| Alkem Laboratories | 65,282 | 27.31 | 13,458 | 3.70% | 2,216 | 41.76 |
Gujarat Themis Biosyn Company Announcements - News Screener
Screen GUJTHEM latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-04 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-01-04 | Report On Special Window For Re-Lodgement Of Transfer Requests Of Physical Shares. | View |
| 2026-01-01 | Closure of Trading Window | View |
| 2025-11-11 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-10 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-10 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-11-10 | Results - Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 2025 | View |
| 2025-11-10 | Board Meeting Outcome for Outcome Of The Board Meeting Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations) | View |
| 2025-11-03 | Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 2025 | View |
| 2025-10-18 | Announcement Under Regulation 30 (LODR) - Commencement Of Commercial Production In Our New Fermentation Plant At Vapi Gujarat. | View |
| 2025-10-16 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-10-14 | Report On Special Window For Re-Lodgement Of Transfer Requests Of Physical Shares. | View |
| 2025-10-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-25 | Closure of Trading Window | View |
| 2025-09-23 | Announcement Under Regulation 30- Clarification | View |
| 2025-09-23 | Clarification sought from Gujarat Themis Biosyn Ltd | - |
| 2025-09-12 | Announcement Under Regulation 30 (Updates) | View |
| 2025-09-12 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-12 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-10 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |